Comment: Possible Toxicity from Propylene Glycol in Lorazepam Infusion

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Annals of Pharmacotherapy

• Publication date

  1997-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/106002809703100525PMID 9161670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propylene glycol-induced side effects during intravenous nitroglycerin therapy

  2004cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• A Method to Produce Sedation in Critically Ill Patients

  1996cited by this paper
• FOCUS ON SAQUINAVIR : AN HIV PROTEINASE INHIBITOR FOR USE WITH NUCLEOSIDE ANALOGUES

  1996cited by this paper
• Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

  1996cited by this paper
• Propylene glycol toxicity caused by prolonged infusion of etomidate.

  1995cited by this paper
• Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema.

  1995cited by this paper
• A case of propylene glycol toxic reaction associated with etomidate infusion.

  1991cited by this paper
• Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy.

  1985cited by this paper
• Hyperosmolality in the burn patient: analysis of an osmolal discrepancy.

  1980cited by this paper
• Propylene glycol as a cause of an elevated serum osmolality.

  1979cited by this paper

• Considerations for deriving a safe intake of propylene glycol.

  2024cites this paper
• Lorazepam

  2019cites this paper
• Iatrogenic and Poison-Derived Acid Base Disorders

  2019cites this paper
• Comparison of different cryopreservation protocols for human umbilical cord tissue as source of mesenchymal stem cells.

  2019cites this paper
• Intravenous Sedatives and Analgesics

  2018cites this paper
• Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature.

  2013cites this paper
• Enhancement of GABAergic Activity: Neuropharmacological Effects of Benzodiazepines and Therapeutic Use in Anesthesiology

  2011cites this paper
• Altering intensive care sedation paradigms to improve patient outcomes.

  2011cites this paper
• Sedatives and Hypnotics

  2011cites this paper
• Altering intensive care sedation paradigms to improve patient outcomes.

  2009cites this paper
• Determination of a Lorazepam Dose Threshold for Using the Osmol Gap to Monitor for Propylene Glycol Toxicity

  2008cites this paper
• Ethylene glycol and propylene glycol toxicity

  2007cites this paper
• Symptom‐Driven Lorazepam Protocol for Treatment of Severe Alcohol Withdrawal Delirium in the Intensive Care Unit

  2007cites this paper
• Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation

  2006cites this paper
• Sedation in PACU: the role of benzodiazepines.

  2005cites this paper
• Toxin-Induced Metabolic Acidosis

  2005cites this paper
• Propylene Glycol–Induced Lactic Acidosis in a Patient with Normal Renal Function: A Proposed Mechanism and Monitoring Recommendations

  2005cites this paper
• Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults*

  2004cites this paper
• Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion

  2003cites this paper
• Acute Tubular Necrosis Associated with Propylene Glycol from Concomitant Administration of Intravenous Lorazepam and Trimethoprim‐Sulfamethoxazole

  2003cites this paper
• Unintentional Human Exposure to Tilmicosin (Micotil®300)

  2003cites this paper
• Pediatric Critical Care Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients

  2002cites this paper
• Critical Care Therapeutics: Advances and controversies in adult ICU sedation: Part 3. Evolving pharmcological treatment issues

  2002cites this paper
• Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients

  2002cites this paper
• Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.

  2002cites this paper
• Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.

  2002cites this paper
• Sedation and analgesia-which way is best?

  2001cites this paper
• Short‐Term Lorazepam Infusion and Concern for Propylene Glycol Toxicity: Case Report and Review

  2001cites this paper
• Editorial II Sedation and analgesia—which way is best?

  2001cites this paper
• Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection.

  2001cites this paper
• Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy

  2001cites this paper
• Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion

  2000cites this paper
• Hypnotics and sedatives

  1999cites this paper
• Stability of lorazepam 1 and 2 mg/mL in glass bottles and polypropylene syringes.

  1998cites this paper
• Correction and Comment: Possible Toxicity from Propylene Glycol in Injectable Drug Preparations

  1997cites this paper